In vitro reversal of supratherapeutic rivaroxaban levels with coagulation factor concentrates

BACKGROUND: A bleeding patient undergoing therapy with new oral anticoagulants is every clinician’s nightmare as no specific reversal agent is available yet. This in vitro study investigated the effect of prothrombin complex concentrate (PCC), recombinant activated factor VII (rFVIIa) and activated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Transfus
Main Authors: Körber, Mareike K., Langer, Elisabeth, Kaufner, Lutz, Sander, Michael, von Heymann, Christian
Formato: Artigo
Idioma:Inglês
Publicado em: Edizioni SIMTI - SIMTI Servizi Srl 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5016310/
https://ncbi.nlm.nih.gov/pubmed/27177413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2016.0205-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados